Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In reply to Nieder.
Bristow RG, Catton C, Vesprini D. Bristow RG, et al. Among authors: vesprini d. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):581. doi: 10.1016/j.ijrobp.2012.08.012. Int J Radiat Oncol Biol Phys. 2013. PMID: 23374994 No abstract available.
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Metcalfe K, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, Eisen A, Foulkes WD, Rosen B, Vesprini D, Sun P, Narod SA. Metcalfe K, et al. Among authors: vesprini d. Breast Cancer Res Treat. 2011 May;127(1):287-96. doi: 10.1007/s10549-010-1336-7. Epub 2011 Jan 9. Breast Cancer Res Treat. 2011. PMID: 21221768
Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients.
Wan BA, Ganesh V, Zhang L, Sousa P, Drost L, Lorentz J, Vesprini D, Lee J, Rakovitch E, Lu FI, Eisen A, Yee C, Lam H, Chow E. Wan BA, et al. Among authors: vesprini d. Clin Oncol (R Coll Radiol). 2018 Jun;30(6):354-365. doi: 10.1016/j.clon.2018.02.026. Epub 2018 Mar 2. Clin Oncol (R Coll Radiol). 2018. PMID: 29496323
Response to: The Survival Time of 8376 Male Breast Cancer Patients.
Wan BA, Ganesh V, Zhang L, Sousa P, Drost L, Lorentz J, Vesprini D, Lee J, Rakovitch E, Lu FI, Eisen A, Yee C, Lam H, Chow E. Wan BA, et al. Among authors: vesprini d. Clin Oncol (R Coll Radiol). 2018 Dec;30(12):818-819. doi: 10.1016/j.clon.2018.08.011. Epub 2018 Sep 10. Clin Oncol (R Coll Radiol). 2018. PMID: 30213703 No abstract available.
A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks.
Tadayyon H, Gangeh M, Sannachi L, Trudeau M, Pritchard K, Ghandi S, Eisen A, Look-Hong N, Holloway C, Wright F, Rakovitch E, Vesprini D, Tran WT, Curpen B, Czarnota G. Tadayyon H, et al. Among authors: vesprini d. Oncotarget. 2019 Jun 11;10(39):3910-3923. doi: 10.18632/oncotarget.26996. eCollection 2019 Jun 11. Oncotarget. 2019. PMID: 31231468 Free PMC article.
An appraisal of genetic testing for prostate cancer susceptibility.
Finch A, Clark R, Vesprini D, Lorentz J, Kim RH, Thain E, Fleshner N, Akbari MR, Cybulski C, Narod SA. Finch A, et al. Among authors: vesprini d. NPJ Precis Oncol. 2022 Jun 22;6(1):43. doi: 10.1038/s41698-022-00282-8. NPJ Precis Oncol. 2022. PMID: 35732815 Free PMC article. Review.
169 results